Jazz Pharmaceuticals (JAZZ) Restructuring Costs (2011 - 2016)
Jazz Pharmaceuticals (JAZZ) recorded quarterly Restructuring Costs of $10.8 million in Q3 2016, up 390.91% quarter-over-quarter from $2.2 million in Q2 2016.
Jazz Pharmaceuticals (JAZZ) Restructuring Costs (2011 - 2016) Analysis & Trends
Jazz Pharmaceuticals' Restructuring Costs history runs 5 years deep, the most recent figure standing at $10.8 million for Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Jazz Pharmaceuticals | 13.91 Bn | 12.06 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 10.80 Mn |
| Jun 30, 2016 | 2.20 Mn |
| Sep 30, 2014 | 700,000.00 |
| Jun 30, 2014 | 4.40 Mn |
| Mar 31, 2014 | 17.10 Mn |
| Jun 30, 2013 | 400,000.00 |
| Jun 30, 2012 | 8.90 Mn |
| Mar 31, 2012 | 3.50 Mn |
| Sep 30, 2011 | 6.00 Mn |